Indegene Limited — PPTs, 30-07-2026: Investor Presentation

Indegene kicked off FY27 with robust Q1 performance, achieving revenue of ₹1,063.1 Cr (USD 112.5M), up 39.7% YoY in INR and 26.5% in USD. Profit After Tax (PAT) was ₹116.2 Cr, with EBITDA margins at 16.9%. The company expanded its active client base to 105, adding 35 new clients YoY, and saw revenue per employee rise 14.2% to $77.1K.

Growth is driven by deepening engagement with large pharma and broadening its client base, with 12 customers now generating over $10 million annually. Strategic focus for FY27 includes moving into higher-value strategic work, scaling GenAI offerings like Generative Engine Optimization, and enhancing proprietary platforms.

Management anticipates improved operating leverage and stronger profitability in H2 FY27 as investments mature. The company is committed to scaling GenAI-powered solutions to advance AI-driven life sciences commercialization, solidifying its market position.